These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 3976457

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing.
    El-Saghir N, Otrock Z, Mufarrij A, Abou-Mourad Y, Salem Z, Shamseddine A, Abbas J.
    Lancet Oncol; 2004 May; 5(5):320-1. PubMed ID: 15120669
    [No Abstract] [Full Text] [Related]

  • 24. Dimethyl sulfoxide therapy in the treatment of vesicant extravasation: two case presentations.
    St Germain B, Houlihan N, D'Amato S.
    J Intraven Nurs; 1994 May; 17(5):261-6. PubMed ID: 7965372
    [Abstract] [Full Text] [Related]

  • 25. European Oncology Nursing Society extravasation guidelines.
    Wengström Y, Margulies A, European Oncology Nursing Society Task Force.
    Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
    [Abstract] [Full Text] [Related]

  • 26. Considerations in the use of lipid-based drug products.
    Madej T.
    J Intraven Nurs; 1998 Sep; 21(6):326. PubMed ID: 10392096
    [No Abstract] [Full Text] [Related]

  • 27. Cutaneous reactions to chemotherapy: commonly seen, less described, little understood.
    Sanborn RE, Sauer DA.
    Dermatol Clin; 2008 Jan; 26(1):103-19, ix. PubMed ID: 18023774
    [Abstract] [Full Text] [Related]

  • 28. IV vesicants: how to avoid extravasation.
    Wood LS, Gullo SM.
    Am J Nurs; 1993 Apr; 93(4):42-6. PubMed ID: 8480802
    [No Abstract] [Full Text] [Related]

  • 29. Extravasation: a dreaded complication of chemotherapy.
    Schrijvers DL.
    Ann Oncol; 2003 Apr; 14 Suppl 3():iii26-30. PubMed ID: 12821535
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Preventing and managing vesicant chemotherapy extravasations.
    Schulmeister L.
    J Support Oncol; 2010 Apr; 8(5):212-5. PubMed ID: 21086879
    [Abstract] [Full Text] [Related]

  • 33. Alterations in wound healing secondary to infusion injury.
    Larson DL.
    Clin Plast Surg; 1990 Jul; 17(3):509-17. PubMed ID: 2199142
    [Abstract] [Full Text] [Related]

  • 34. Case report: topical DMSO for mitomycin-C-induced skin ulceration.
    Alberts DS, Dorr RT.
    Oncol Nurs Forum; 1991 Jul; 18(4):693-5. PubMed ID: 1906166
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antineoplastic vesicant extravasation.
    Beason R.
    J Intraven Nurs; 1990 Jul; 13(2):111-4. PubMed ID: 2313459
    [Abstract] [Full Text] [Related]

  • 37. Doxorubicin hydrochloride (Adriamycin) and related soft tissue injuries.
    Wasserstrum A.
    J Med Soc N J; 1979 Nov; 76(12):838-40. PubMed ID: 295370
    [No Abstract] [Full Text] [Related]

  • 38. Developing extravasation protocols and monitoring outcomes.
    Camp-Sorrell D.
    J Intraven Nurs; 1998 Nov; 21(4):232-9. PubMed ID: 9866539
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Granulocyte macrophage-colony stimulating factor for treatment of chemotherapy extravasation.
    Shamseddine AI, Khalil AM, Kibbi AG, Abu Nasr TA, Seoud MA, El Saghir NS.
    Eur J Gynaecol Oncol; 1998 Nov; 19(5):479-81. PubMed ID: 9863917
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.